TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -2 | -2 | 22 | -54 | -75 | 0 | -22 |
| S | %wins | 100 | 100 | 0 | 100 | 100 | 80 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/30/21 18:42 | 6/28/21 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | S.d | -1,292 | 2.87 | 0 | -450 | -89 | 56 | D | ||||||||||||||
6/3/11 17:01 | 6/2/11 | ANX | Adventrx Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Culley Brian M | CA | O | CEO | S | -12 | 2.44 | 1 | -5 | -100 | 0 | D | -18 | 11 | 27 | 16 | 4 | -6 | 5 | -2 | -2 | -2 | 22 | -54 | -75 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |